Biomea Fusion prices $40M public offering of 19.45M shares and warrants at $2.00/unit

Biomea Fusion, Inc.

Offering of 19.45M common shares and 19.45M accompanying warrants; 550K pre-funded warrants for certain investors.
Combined price $2.00 per share + warrant, $1.9999 per pre-funded warrant + warrant; gross proceeds ~$40M.
Common stock warrants exercisable at $2.50/share, expire 18 months from issuance; pre-funded warrants at $0.0001.
Expected close June 20, 2025; net proceeds ~$37.1M ($42.7M if underwriter option exercised in full).
Jefferies acting as sole book-runner; proceeds for general corporate purposes and clinical development.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.